Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Axial Bone Densitometer Market size was valued at USD 1.4 billion in 2024 and is projected to reach USD 2.8 billion by the end of 2037, rising at a CAGR of 7.4% during the forecast period, i.e., 2025-2037. In 2025, the industry size of axial bone densitometer is assessed at 1.5 billion.
The worldwide patient pool is vigorously expanding, and axial bone densitometers are being utilized to combat certain health disorders. The global market is witnessing growth fueled by the growing burden of osteoporosis, the rising geriatric population, and innovative advancements in the diagnostic sector. In this regard, the National Osteoporosis Foundation states that over 9.7 million individuals in the U.S. are affected by osteoporosis, and 43 million people are at risk due to low bone density. Hence, this aspect highly necessitates the requirement of frequent bone density scans, thereby driving business in this sector.
Furthermore, the aspect of trade and supply chain is yet another major driver propelling upliftment in the axial bone densitometer market. In this context, it is reported that the supply chain of this equipment highly relies on components such as X-ray, tubes, detectors, and calibration phantoms, which are critically drawn from the U.S., Germany, and Japan. Besides, the U.S. FDA notes that the APIs used for contrast agents in secondary tests are imported from China and India, supplying over 60%. Simultaneously, the U.S. leads in the imports with USD 1.3 billion in medical imaging parts in 2023, whereas in terms of exports EU and Japan dominate with USD 900 million in assembled systems.
Axial Bone Densitometer Sector: Growth Drivers and Challenges
Growth Drivers
-
Technological advancements: The ongoing advancements in terms of technological innovation are significantly influencing the market demand. In this context NIH study reports that manufacturers such as Hologic and GE Healthcare launched AI-based densitometers that remarkably increase the accuracy and reduce scan time by 32%. Besides, NIH made an investment of over USD 10 million for R&D in portable densitometers to improve access in the rural and remote areas. Hence, such innovations create a positive impact on the overall market growth, especially in emerging regions.
-
Affordable early intervention: Axial bone densitometers are proven to be affordable and reduce hospitalization costs, which makes them suitable for market development. For instance, in 2022 AHRQ study found that early detection of osteoporosis utilization of these devices diminishes the hospital costs by 20%, thus leading to the conservation of USD 2.2 billion for more than 2 years. Meanwhile, in the U.K., after the implementation of DXA testing, there has been a 16% reduction in hip fracture admissions, which reinforces the axial bone densitometers market progression.
Historical Patient Growth and Its Impact on the Axial Bone Densitometer Market
The axial bone densitometers market is witnessing notable expansion driven by the rising patient pool being affected by osteoporosis and age-associated bone disorders over the last decade. Additionally, the regions such as the U.S., Germany, and Japan witnessed a steady growth in ABD utilization owing to the improved diagnostic coverage. Simultaneously, the emerging nations such as India and China experienced enhanced adoption due to the expanded awareness. This exponential augmentation in terms of patient pool has encouraged the manufacturers to leverage affordable and portable models, thereby positively impacting industrial upliftment.
Below is a detailed breakdown of patient growth across key markets:
|
Country |
2010 |
2015 |
2020 |
CAGR (2010-2020) |
|
U.S. |
2.3 |
3 |
3.7 |
5.7% |
|
Germany |
1.6 |
2.2 |
2.5 |
5.2% |
|
France |
1.4 |
1.8 |
2.2 |
5.4% |
|
Spain |
1.1 |
1.3 |
1.6 |
6.1% |
|
Australia |
0.7 |
0.9 |
1.1 |
6.2% |
|
Japan |
2.1 |
2.7 |
3.4 |
6.1% |
|
India |
0.5 |
0.8 |
1.3 |
14.1% |
|
China |
1.2 |
2.4 |
4.2 |
15.1% |
Feasible Expansion Models Shaping the Axial Bone Densitometer Market
There are revolutionary changes in the market owing to the tactical models, such as accessibility and profitability. For instance, in India, the partnership between suppliers and domestic clinics increased the revenue by 13.4% between 2022 to 2024 through lease-to-own agreements as of NHP data. Besides, the CMS notes that in the U.S., expanded DXA coverage led to a revenue boost of 8.3% in 2023. Therefore, these models underscore the crucial role of cost-optimized distribution, AI deployment, and policy alignment in boosting market expansion.
Revenue Feasibility Models (2020–2024)
|
Model |
Region |
Revenue Growth |
Key Driver |
|
Lease-to-Own Agreements |
India |
+13.4% (2022–2024) |
Rural clinic partnerships |
|
Medicare Expansion |
U.S. |
+8.3% (2023) |
Broader DXA coverage |
|
State Procurement |
China |
+21.3% CAGR |
Government tenders |
|
Refurbished Units |
South Africa |
+16% (2021–2023) |
Affordable imports |
Challenges
-
Lack of standardized protocols: This remains a major bottleneck in the market, negatively impacting the treatment rollout. WHO notes that only 42% of nations in Europe follow screening guidelines, thus creating an uneven demand. For example, Hologic lobbied France to impose mandatory DXA scans for elderly people, which tremendously increased sales by 16.4%.
-
Emergence of low-cost alternatives: The presence of refurbished and low-cost alternatives marks a major hurdle in the axial bone densitometer market, causing hindrance in emerging nations. In Africa, the merchandise witnessed 50% domination in terms of refurbished units, diminishing sales of new devices. However, GE Healthcare overcame this with the launch of USD 22k entry-level devices in Nigeria that captured 22.4% of market share.
Axial Bone Densitometer Market: Key Insights
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
7.4% |
|
Base Year Market Size (2024) |
USD 1.4 billion |
|
Forecast Year Market Size (2037) |
USD 2.8 billion |
|
Regional Scope |
|
Axial Bone Densitometer Segmentation
End User (Hospitals & Diagnostic Centers, Specialty Clinics, Research Institutions)
Based on end user, the hospitals & diagnostic centers segment is expected to garner the highest share of 52.6% in the market by the end of 2037. The segment’s dominance is critically influenced by its capability in detecting and managing complex bone conditions. The main advantage caters to the Medicare reimbursement for DXA scans in the U.S. Besides, in hospitals, the axial bone densitometer procurement grew by 13.7% in 2023 owing to the osteoporosis screening mandates, hence allowing the segment to dominate abruptly.
Product Type (Dual-Energy X-ray Absorptiometry, Quantitative Ultrasound, Peripheral DXA)
In terms of product type, the dual-energy x-ray absorptiometry segment is projected to grow at a considerable rate, with a share of 48.2% in the market during the forecast period. The segment’s upliftment is facilitated by the mounting support from regulatory frameworks, with the U.S. FDA approving AI- AI-enhanced DXA for fracture risk prediction. Besides, the National Institute of Health notes that these systems account for over 88% of detection tests covered by Medicare, thus creating a prolific opportunity for the segment’s growth.
Our in-depth analysis of the global market includes the following segments:
|
End User |
|
|
Product Type |
|
|
Technology |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportAxial Bone Densitometer Industry - Regional Synopsis
North America Market Analysis
North America is projected to account for the largest share of 40.5% in the axial bone densitometer market during the forecast timeline. The region’s growth is effectively attributed to the presence of 6.8% CAGR, Medicare allocations, and a rising number of disease incidences. The U.S. accounts for 86% of the regional share, while the Canada market is growing at 5.8% CAGR owing to the provincial osteoporosis programs. Besides, the aspect of effective reimbursement policies and federal budget allocation of USD 855 million contributes to the market expansion in the region.
The U.S. is a major player in the North America axial bone densitometer market, stimulated by factors such as Medicare and Medicaid healthcare provisions. The U.S. FDA reports that AI-based dual-energy x-ray absorptiometry systems have been remarkably adopted by 32% of hospitals in the country, thus reflecting an expanded demand. Besides the Medicare 2025 expansion in coverage for portable densitometers is further expected to boost access. Furthermore, the CDC states that over 12 million DXA scans are being performed annually due to the increased burden of osteoporosis.
There is a huge exposure for the axial bone densitometer market in Canada, which is readily propelled by federal and provincial budget allocations. Based on this factor, the provincial system mandates screening programs, with Ontario enhancing its coverage for 220,000 scans annually. Besides, Health Canada extends its support with 2024 reimbursement reforms, aiming to reduce the waiting period by 25%. Also, the aspect of axial bone densitometers in rural areas is experiencing a 15.7% increase in sales, hence facilitating an optimistic opportunity for market expansion.
Asia Pacific Market Statistics
The Asia Pacific’s axial bone densitometer market is anticipated to witness the fastest growth in the assessed timeframe, with a considerable share of 26.7%. The region’s prominence is highly subject to the presence of key regions such as India, China, Japan, South Korea, Malaysia, and their unique developmental approaches. Also, the region witnesses the expanded incidence of osteoporosis owing to the proximity of aging demographics. Besides the national screening mandates, funding grants for AI-integrated systems also foster a favorable business environment in the region.
China is the dominating country in the regional axial bone densitometer market, holding a considerable share of 32.5% boosted through domestic healthcare modernization initiatives. The NMPA has made a provision with over 16% DXA units approved annually since 2023 that resulting in 4.7 million scans in 2024. Besides the Healthy China initiative imposed mandatory ABD installations in almost all teir-2-hospitals granting USD 2.2 billion in federal funding. Further, the domestic manufacturers such as Mindray and United Imaging control 72% market, emphasizing cost advantages in terms of imports.
India is unfolding remarkable growth opportunities in the axial bone densitometer market, capturing 18.5% of regional market share, owing to the proximity of robust healthcare infrastructure and government-backed initiatives. PMJAY notes that Ayushman Bharat granted USD 185 million for portable ABD deployment in rural areas, aiding access for 514 million individuals having risk. Besides, the country hosts 1.3 million cases of osteoporosis, with only 16% of facilities comprising DXA scanners, reflecting the unmet demand. Further, the partnerships between firms and healthcare facilities boost adoption in the country.
Companies Dominating the Axial Bone Densitometer Landscape
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The axial bone densitometer market is considered to be extremely consolidated, with firms such as Hologic, GE Healthcare, and Siemens collectively accounting for over 50% of the market share. Global leaders are making investments in AI-based diagnostics and portable DXA systems to establish their footprint in emerging nations. Besides the well-planned collaborations, such as GE Healthcare with Apollo Hospitals, are expanding access in the high-end growth regions, such as the Asia Pacific. Meanwhile, ultrasound alternatives in Japan and regulatory compliance in Europe fundamentally shape the competitive landscape in the global market.
Below is the list of some prominent players in the industry:
|
Company Name (Country) |
Market Share (2024) |
Industry Focus |
|
Hologic Inc. (U.S.) |
23.4% |
Leading DXA systems (Horizon, Discovery); AI-integrated bone density analysis. |
|
GE Healthcare (U.S.) |
19.2% |
Lunar iDXA series: focus on portable and hospital-based densitometers. |
|
Siemens Healthineers (Germany) |
16.3% |
Versatile DXA-CT hybrid systems; strong EU and APAC presence. |
|
Osteosys (South Korea) |
12.2% |
Cost-effective DXA scanners (EXA3000); expanding in emerging markets. |
|
Medilink (France) |
8.3% |
Specializing in compact, portable ABDs for rural clinics. |
|
DMS Imaging (France) |
xx% |
STRATOS and APEX systems: high-precision DXA for osteoporosis management. |
|
BeamMed (Israel) |
xx% |
Focus on peripheral DXA (pDXA) and ultrasound-based bone density assessment. |
|
Swissray (Switzerland) |
xx% |
ddRTechnology for low-dose, high-resolution DXA imaging. |
|
Scanflex Healthcare (Sweden) |
xx% |
Affordable DXA solutions for Nordic and Eastern European markets. |
|
Osteometer MediTech (Denmark) |
xx% |
DTX-200 DexaCare; emphasis on pediatric and geriatric bone health. |
|
CyberLogic (U.S.) |
xx% |
AI-driven fracture risk prediction software for DXA systems. |
|
OsteoSys (India) |
xx% |
Budget-friendly DXA scanners targeting India’s mid-tier hospitals. |
|
BM Tech (South Korea) |
xx% |
Compact ABDs for private clinics; growing in Southeast Asia. |
|
OsteoCare (Malaysia) |
xx% |
Localized DXA solutions with Malay-language support. |
|
Furuno Electric (Japan) |
xx% |
Ultrasound-based bone densitometers (Sonost-2000): niche in Japanese clinics. |
Below are the areas covered for each company under the top 15 global manufacturers:
Recent Developments
- In May 2024, Osteosys launched EXA 4000 Portable DXA, a lightweight, battery-operated DXA scanner for rural and mobile clinics, for which sales surged by 16.2% in Asia-Pacific, with 1,200 units sold in India alone.
- In March 2024, Hologic introduced an AI-powered upgrade to its Horizon DXA system, Horizon DXA AI Suite, enabling automated fracture risk assessment and osteoporosis management.
Author Credits: Radhika Pawar
- Report ID: 7734
- Published Date: Jun 10, 2025
- Report Format: PDF, PPT
